SMTL ID : 8v4x.3 (3 other biounits)

Structure of MALT1 in complex with an allosteric inhibitor

Coordinates

PDB Format Compare

Method

X-RAY DIFFRACTION 2.49 Å

Oligo State

homo-dimer

Ligands

2 x PHQ- VAL- ARG- PRO- ARG- CF0: Inhibitor peptide(Non-covalent)

PHQ-VAL-ARG-PRO-ARG-CF0.1: 21 residues within 4Å: Chain A: K.26, L.27, K.28, A.29, P.30, D.33, A.81, G.82, H.83, G.84, D.130, C.132, A.166, F.167, E.168, I.169, Q.170, H.171, G.177, L.209, K.213 23 PLIP interactions: 23 interactions with chain A Hydrophobic interactions: A:L.27, A:F.167, A:F.167, A:F.167, A:E.168, A:I.169, A:L.209 Hydrogen bonds: A:K.28, A:H.83, A:G.84, A:D.130, A:C.132, A:A.166, A:E.168, A:E.168, A:Q.170, A:Q.170 Water bridges: A:D.130, A:G.177 Salt bridges: A:D.33, A:D.130, A:E.168, A:E.168 PHQ-VAL-ARG-PRO-ARG-CF0.2: 22 residues within 4Å: Chain B: P.25, K.26, L.27, A.29, P.30, D.33, Y.79, A.81, G.82, H.83, G.84, D.130, C.132, E.165, A.166, F.167, E.168, I.169, Q.170, H.171, L.209, K.213 20 PLIP interactions: 20 interactions with chain B Hydrophobic interactions: B:L.27, B:F.167, B:F.167, B:I.169, B:L.209 Hydrogen bonds: B:K.26, B:K.26, B:Y.79, B:G.84, B:C.132, B:A.166, B:E.168, B:E.168, B:Q.170, B:Q.170, B:Q.170 Water bridges: B:G.177 Salt bridges: B:D.33, B:D.130, B:E.168

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Plotnik, J.P. et al., Inhibition of MALT1 and BCL2 induces synergistic anti-tumor activity in models of B cell lymphoma. Mol.Cancer Ther. (2024)

Release Date

2024-05-01

Peptides

Mucosa-associated lymphoid tissue lymphoma translocation protein 1: AB

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
E

B
F

Mucosa-associated lymphoid tissue lymphoma translocation protein 1

Related Entries With Identical Sequence